This is a non-ticketed session.

This course has a maximum of 120 seats. Courtesy tickets are no longer available for this course.
This presentation will review recent advances in the treatment of oral, head and neck cancer, including computer aided surgical simulation, transoral robotic surgery and novel systemic agents for use in the definitive and metastatic setting. The results of ongoing and recently completed clinical trials will be emphasized.

1. Discuss recent technological advances in the surgical treatment of oral, head and neck cancer;
2. Discuss recent practice changing clinical trials that have influenced the surgical management of oral cancer; and
3. Explain current and evolving clinical trials that will affect the treatment of oral, head and neck cancer.